The current status of prostate cancer treatment and PSMA theranostics.

Uemura, Motohide; Watabe, Tadashi; Hoshi, Seiji; Tanji, Ryo; Yaginuma, Kei; Kojima, Yoshiyuki

Uemura, Motohide; Watabe, Tadashi; Hoshi, Seiji; Tanji, Ryo; Yaginuma, Kei; Kojima, Yoshiyuki.

Afiliación

Uemura M; Department of Urology, Fukushima Medical University School of Medicine, 1, Hikarigaoka, Fukushima 960-1295, Japan.
Watabe T; Department of Urology, Iwase General Hospital, Sukagawa, Fukushima, Japan.
Hoshi S; Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Tanji R; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yaginuma K; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kojima Y; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Ther Adv Med Oncol ; 15: 17588359231182293, 2023.

Article en En | MEDLINE | ID: mdl-37424944

Palabras clave

PSMA; diagnosis; prostate cancer; radiotherapy; theranostics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google